首页> 外文OA文献 >Using Whole Genome Amplification (WGA) of Low-Volume Biopsies to Assess the Prognostic Role of EGFR, KRAS, p53, and CMET Mutations in Advanced-Stage Non-small Cell Lung Cancer (NSCLC)

【2h】

Using Whole Genome Amplification (WGA) of Low-Volume Biopsies to Assess the Prognostic Role of EGFR, KRAS, p53, and CMET Mutations in Advanced-Stage Non-small Cell Lung Cancer (NSCLC)

机译：使用小批量活检的全基因组扩增（WGA）评估EGFR，KRAS，p53和CMET突变在晚期非小细胞肺癌（NSCLC）中的预后作用

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Lim Elaine H.; Zhang Shen-Li; Li Jia-Liang; Yap Wee-See; Howe Tse-Chiang; Tan Bien-Peng; Lee Yong-Shyan; Wong Daniel; Khoo Kay-Leong; Seto Kar-Yin; Tan Lenny; Agasthian Thirugananam; Koong Heng-Nung; Tam John; Tan Christie; Caleb Michael; Chang Alex; Ng Alan; Tan Patrick;
展开▼
作者单位

展开▼
年度 2009
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Using whole genome amplification (WGA) of low-volume biopsies to assess the prognostic role of EGFR, KRAS, p53, and CMET mutations in advanced-stage non-small cell lung cancer (NSCLC). [J] . Lim EH, Zhang SL, Li JL, Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2009,第1期

机译：使用小批量活检的全基因组扩增（WGA）评估EGFR，KRAS，p53和CMET突变在晚期非小细胞肺癌（NSCLC）中的预后作用。
2. Can mutations of EGFR and KRAS in serum be predictive and prognostic markers in patients with advanced non-small cell lung cancer (NSCLC)? [J] . Seung Tae Kim, Jae Sook Sung, Uk Hyun Jo, Medical oncology . 2013,第1期

机译：晚期非小细胞肺癌（NSCLC）患者的血清EGFR和KRAS突变是否可以作为预测和预后标志物？
3. Prognostic and predictive effects of TP53 co-mutation in patients with EGFR-mutated non-small cell lung cancer (NSCLC) [J] . Labbe Catherine, Cabanero Michael, Korpanty Grzegorz J., Lung cancer: Journal of the International Association for the Study of Lung Cancer . 2017,第期

机译：TP53共突患者EGFR-突变非小细胞肺癌（NSCLC）患者的预后及预测作用
4. In Non-Small Cell Lung Cancer, Can Radiomic Features Predict EGFR Mutations? [C] . Jiayan Liu, Lin Liu, Yue Ma, IEEE International Conference on Mechatronics and Automation . 2019

机译：在非小细胞肺癌中，放射学特征可以预测EGFR突变吗？
5. 4HPR-X radiation mechanisms of interactions in non-small cell lung cancer (NSCLC) cells in vitro. [D] . Nasca, Melita Maria. 2002

机译：4HPR-X辐射在非小细胞肺癌（NSCLC）细胞中相互作用的体外机制。
6. Role of next generation sequencing-based liquid biopsy in advanced non-small cell lung cancer patients treated with immune checkpoint inhibitors: impact of STK11 KRAS and TP53 mutations and co-mutations on outcome [O] . Alberto Pavan, Andrea Boscolo Bragadin, Lorenzo Calvetti, 2021

机译：下一代测序液体活检在免疫检查点抑制剂治疗的先进非小细胞肺癌患者中的作用：STK11KRAS和TP53突变的影响和共生突变
7. Impact on KRAS-subtypes and TP53 mutations on the prognostic value of KRAS/KEAP1 comutations in non-small cell lung cancer (NSCLC) [O] . M. Scheffler, R. Frank, M.A. Ihle, 2019

机译：对克拉斯 - 亚型和TP53突变对非小细胞肺癌（NSCLC）的克拉斯/ keap1性关系的影响

Using Whole Genome Amplification (WGA) of Low-Volume Biopsies to Assess the Prognostic Role of EGFR, KRAS, p53, and CMET Mutations in Advanced-Stage Non-small Cell Lung Cancer (NSCLC)

著录项

引文网络

相似文献

相关主题

期刊订阅